Sunitinib Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

February 12, 2019

Study Completion Date

February 12, 2019

Conditions
Endometrial AdenocarcinomaEndometrial Endometrioid AdenocarcinomaEndometrial Serous AdenocarcinomaRecurrent Uterine Corpus CarcinomaStage IVA Uterine Corpus Cancer AJCC v7Stage IVB Uterine Corpus Cancer AJCC v7Uterine CarcinosarcomaUterine Corpus Carcinosarcoma
Interventions
DRUG

Sunitinib Malate

Given PO

Trial Locations (29)

21201

University of Maryland/Greenebaum Cancer Center, Baltimore

46628

Northern Indiana Cancer Research Consortium, South Bend

46804

Fort Wayne Medical Oncology and Hematology Inc - Jefferson Boulevard, Fort Wayne

48109

University of Michigan Comprehensive Cancer Center, Ann Arbor

49085

Oncology Care Associates PLLC, Saint Joseph

53226

Froedtert and the Medical College of Wisconsin, Milwaukee

60153

Loyola University Medical Center, Maywood

60201

Evanston Hospital CCOP, Evanston

60426

Ingalls Memorial Hospital, Harvey

60435

Joliet Oncology-Hematology Associates Limited, Joliet

60637

University of Chicago Comprehensive Cancer Center, Chicago

61615

Illinois CancerCare-Peoria, Peoria

62526

Decatur Memorial Hospital, Decatur

62702

Central Illinois Hematology Oncology Center, Springfield

Southern Illinois University School of Medicine, Springfield

63141

Mercy Hospital Saint Louis, St Louis

90033

USC / Norris Comprehensive Cancer Center, Los Angeles

90211

Tower Cancer Research Foundation, Beverly Hills

91010

City of Hope Comprehensive Cancer Center, Duarte

91030

City of Hope South Pasadena, South Pasadena

95817

University of California Davis Comprehensive Cancer Center, Sacramento

T6G 1Z2

Cross Cancer Institute, Edmonton

V5Z 4E6

BCCA-Vancouver Cancer Centre, Vancouver

L8V 5C2

Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton

K7L 2V7

Kingston Health Sciences Centre, Kingston

K1H 8L6

Ottawa Hospital and Cancer Center-General Campus, Ottawa

M4N 3M5

Odette Cancer Centre- Sunnybrook Health Sciences Centre, Toronto

M5G 2M9

University Health Network-Princess Margaret Hospital, Toronto

H3T 1E2

Jewish General Hospital, Montreal

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00478426 - Sunitinib Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer | Biotech Hunter | Biotech Hunter